Abstract:Atherosclerosis is one of the leading causes of cardiovascular diseases and is triggered by endothelial damage, local lipid cumulation, and inflammation. Despite the conventional medication treatment, nanosized drug carriers have become promising candidates for efficient drug delivery with lower side effects. However, the development of problems in nanocarriers such as drug leakage, accumulating efficiency, and accurate drug release, as well as the specific recognition of atherosclerotic plaques, still needs to be checked. In this study, a lipid-specific fluorophore (LFP) has been designed, which is further packaged with a reactive oxygen species (ROS)-responsive prednisolone (Pred) prodrug copolymer [PMPC-P(MEMA-co-PDMA)] to self-assemble into micelles. can be further coated with red blood cell (RBC) membrane to obtain surface-biomimetic nanoparticles (RBC/), demonstrating prolonged circulation, minimal drug leakage, and better accumulation at the plaques. With ROS responsiveness, RBC/ can be interrupted at inflammatory atherosclerotic tissue with overexpressed ROS, followed by the dissociation of Pred from the polymer backbone and the release of LFP to combine with the rich lipid in the plaques. An accurate anti-inflammation and lipid-specific fluorescent imaging of atherosclerotic lesions was performed and further proven on ApoE–/– mice; this holds prospective potential for atherosclerosis theranostics.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c08552?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c08552</a>.Materials purchase, synthesis of LFP and polymer, ROS responsiveness, in vitro cytotoxicity, anti-inflammation effect, animal model construction, acute toxicity evaluation, pharmacokinetics study and statistical analysis, 1H NMR spectra, high-resolution mass spectrometry, cmc determination, size stability, in vitro cytotoxicity, distribution in organs, pharmacokinetics, and in vivo acute toxicity (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c08552/suppl_file/am1c08552_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A preliminary study on the biomimetic drug delivery system targeting atherosclerotic lesions

Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications

Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect

Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics

Biomimetic nanoparticles: U937 cell membranes based core–shell nanosystems for targeted atherosclerosis therapy

Plaque-hyaluronidase-responsive High-Density-lipoprotein-mimetic Nanoparticles for Multistage Intimal-Macrophage-targeted Drug Delivery and Enhanced Anti-Atherosclerotic Therapy.

A Macrophage Membrane-Functionalized, Reactive Oxygen Species-Activatable Nanoprodrug to Alleviate Inflammation and Improve the Lipid Metabolism for Atherosclerosis Management

Biomimetic Liposomes Hybrid with Platelet Membranes for Targeted Therapy of Atherosclerosis

Biomimetic Nanotherapies: Red Blood Cell Based Core–Shell Structured Nanocomplexes for Atherosclerosis Management

Unleashing the biomimetic targeting potential of platelet-derived nanocarriers on atherosclerosis

Biomimetic Macrophage Membrane and Lipidated Peptide Hybrid Nanovesicles for Atherosclerosis Therapy

Application of Therapeutical Nanoparticles with Neutrophil Membrane Camouflaging for Inflammatory Plaques Targeting against Atherosclerosis

Phagocytosis of polymeric nanoparticles aided activation of macrophages to increase atherosclerotic plaques in ApoE−/− mice

Pro-efferocytosis biomimetic nanocomplexes for targeted atherosclerosis therapy through promoting macrophage re-polarization and inhibiting senescence

Platelet Membrane Biomimetic Nanoparticles Combined With UTMD to Improve the Stability of Atherosclerotic Plaques

Red Blood Cell Membrane Spontaneously Coated Nanoprodrug Based on Phosphatidylserine for Antiatherosclerosis Applications

Macrophage Membrane Spontaneously Encapsulated Cyclodextrin-Based Nanomedicines for Improving Lipid Metabolism and Inflammation in Atherosclerosis

Intelligent response micelles with high andrographolide loading for the effective treatment of atherosclerosis

Pretreatment of macrophage-membrane-coated nanoparticles for therapeutical targeting of P. gingivalis-accelerated atherosclerosis

Biomimetic nanoparticles targeting atherosclerosis for diagnosis and therapy

Research_9845459 1..12